Switch theme
Sign up to access all valuation multiples
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.
2017
10.5K+
LTM Revenue $3.3B
LTM EBITDA $685M
$3.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AdaptHealth has a last 12-month revenue (LTM) of $3.3B and a last 12-month EBITDA of $685M.
In the most recent fiscal year, AdaptHealth achieved revenue of $3.3B and an EBITDA of $628M.
AdaptHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
See AdaptHealth valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| Gross Profit | $801M | XXX | $681M | XXX | XXX | XXX |
| Gross Margin | 25% | XXX | 21% | XXX | XXX | XXX |
| EBITDA | $685M | XXX | $628M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| EBIT | $315M | XXX | $277M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $104M | XXX | $90.4M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.9B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, AdaptHealth's stock price is $9.
AdaptHealth has current market cap of $1.2B, and EV of $3.3B.
See AdaptHealth trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.3B | $1.2B | XXX | XXX | XXX | XXX | $1.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, AdaptHealth has market cap of $1.2B and EV of $3.3B.
AdaptHealth's trades at 1.0x EV/Revenue multiple, and 5.2x EV/EBITDA.
Equity research analysts estimate AdaptHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AdaptHealth has a P/E ratio of 11.7x.
See valuation multiples for AdaptHealth and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EV (current) | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| EV/Revenue | 1.0x | XXX | 1.0x | XXX | XXX | XXX |
| EV/EBITDA | 4.8x | XXX | 5.2x | XXX | XXX | XXX |
| EV/EBIT | 10.3x | XXX | 11.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 11.7x | XXX | 13.4x | XXX | XXX | XXX |
| EV/FCF | 15.7x | XXX | 13.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAdaptHealth's last 12 month revenue growth is 2%
AdaptHealth's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $39K for the same period.
AdaptHealth's rule of 40 is -5% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AdaptHealth's rule of X is 25% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for AdaptHealth and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -5% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 25% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $39K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AdaptHealth acquired XXX companies to date.
Last acquisition by AdaptHealth was XXXXXXXX, XXXXX XXXXX XXXXXX . AdaptHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was AdaptHealth founded? | AdaptHealth was founded in 2017. |
| Where is AdaptHealth headquartered? | AdaptHealth is headquartered in United States of America. |
| How many employees does AdaptHealth have? | As of today, AdaptHealth has 10.5K+ employees. |
| Who is the CEO of AdaptHealth? | AdaptHealth's CEO is Ms. Suzanne M. Foster. |
| Is AdaptHealth publicy listed? | Yes, AdaptHealth is a public company listed on NAS. |
| What is the stock symbol of AdaptHealth? | AdaptHealth trades under AHCO ticker. |
| When did AdaptHealth go public? | AdaptHealth went public in 2018. |
| Who are competitors of AdaptHealth? | Similar companies to AdaptHealth include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of AdaptHealth? | AdaptHealth's current market cap is $1.2B |
| What is the current revenue of AdaptHealth? | AdaptHealth's last 12 months revenue is $3.3B. |
| What is the current revenue growth of AdaptHealth? | AdaptHealth revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of AdaptHealth? | Current revenue multiple of AdaptHealth is 1.0x. |
| Is AdaptHealth profitable? | Yes, AdaptHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AdaptHealth? | AdaptHealth's last 12 months EBITDA is $685M. |
| What is AdaptHealth's EBITDA margin? | AdaptHealth's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of AdaptHealth? | Current EBITDA multiple of AdaptHealth is 4.8x. |
| What is the current FCF of AdaptHealth? | AdaptHealth's last 12 months FCF is $208M. |
| What is AdaptHealth's FCF margin? | AdaptHealth's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of AdaptHealth? | Current FCF multiple of AdaptHealth is 15.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
